Back to search
FDAFDA · Food and drugs·Recall number Z-0042-2020

Online TDM Vancomycin Gen.3 (100 tests) Catalog # 06779336190 Analyzer/Module: cobas c 311 and cobas c 501/502

Published October 16, 2019 · Recall initiated: July 23, 2019

Summary

FDA records medical device Class II recall Z-0042-2020, published October 16, 2019 and initiated July 23, 2019. Recalling firm: Roche Diagnostics Operations, Inc.; Status: Terminated; Reported quantity: 27676 units; Lot: All Lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Inaccurately Low Sample Results

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Roche Diagnostics Operations, Inc.
Distributor
AK AL AR AZ CA CO CT DC DE FL GA GU HI IA ID IL IN KS KY LA MA MD ME MI MN MO MS MT NC ND NE NH NJ NM NV NY OH OK OR PA PR RI SC SD TN TX UT VA VT WA WI WV WY
Lot
All Lots
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Online TDM Vancomycin Gen.3 (100 tests) Catalog # 06779336190 Analyzer/Module: cobas c 311 and cobas c 501/502 recalled?

Yes. FDA published recall Z-0042-2020 on October 16, 2019. Reported hazard: Inaccurately Low Sample Results

What should I do if I have this product?

Voluntary: Firm initiated · Letter